(1R,4S,5R)-4-(5-((R)-2-amino-4,5-dihydro-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-yl)-6-oxo-5,7-diazaspiro[bicyclo[3.2.1]octane-2,1'-cyclopropan]-7-yl hydrogen sulfate

(1R,4S,5R)-4-(5-((R)-2-amino-4,5-dihydro-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-yl)-6-oxo-5,7-diazaspiro[bicyclo[3.2.1]octane-2,1'-cyclopropan]-7-yl hydrogen sulfate Struktur
2365454-58-4
CAS-Nr.
2365454-58-4
Englisch Name:
(1R,4S,5R)-4-(5-((R)-2-amino-4,5-dihydro-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-yl)-6-oxo-5,7-diazaspiro[bicyclo[3.2.1]octane-2,1'-cyclopropan]-7-yl hydrogen sulfate
Synonyma:
(1R,4S,5R)-4-(5-((R)-2-amino-4,5-dihydro-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-yl)-6-oxo-5,7-diazaspiro[bicyclo[3.2.1]octane-2,1'-cyclopropan]-7-yl hydrogen sulfate
CBNumber:
CB811556918
Summenformel:
C13H17N7O6S
Molgewicht:
399.38
MOL-Datei:
2365454-58-4.mol

(1R,4S,5R)-4-(5-((R)-2-amino-4,5-dihydro-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-yl)-6-oxo-5,7-diazaspiro[bicyclo[3.2.1]octane-2,1'-cyclopropan]-7-yl hydrogen sulfate Eigenschaften

Dichte
2.35±0.1 g/cm3(Predicted)
pka
-4.59±0.18(Predicted)

Sicherheit

(1R,4S,5R)-4-(5-((R)-2-amino-4,5-dihydro-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-yl)-6-oxo-5,7-diazaspiro[bicyclo[3.2.1]octane-2,1'-cyclopropan]-7-yl hydrogen sulfate Chemische Eigenschaften,Einsatz,Produktion Methoden

(1R,4S,5R)-4-(5-((R)-2-amino-4,5-dihydro-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-yl)-6-oxo-5,7-diazaspiro[bicyclo[3.2.1]octane-2,1'-cyclopropan]-7-yl hydrogen sulfate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(1R,4S,5R)-4-(5-((R)-2-amino-4,5-dihydro-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-yl)-6-oxo-5,7-diazaspiro[bicyclo[3.2.1]octane-2,1'-cyclopropan]-7-yl hydrogen sulfate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate

  • (1R,4S,5R)-4-(5-((R)-2-amino-4,5-dihydro-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-yl)-6-oxo-5,7-diazaspiro[bicyclo[3.2.1]octane-2,1'-cyclopropan]-7-yl hydrogen sulfate
  • 2365454-58-4
Copyright 2019 © ChemicalBook. All rights reserved